- Home
- BMO vs MDT Comparison
BMO vs MDT Comparison
Compare BMO & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMO | MDT |
|---|---|---|
| Founded | 1817 | 1949 |
| Country | Canada | Ireland |
| Employees | 53000 | N/A |
| Industry | Commercial Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.4B | 105.3B |
| IPO Year | N/A | 2014 |
Fundamental Metrics
Financial Performance| Metric | BMO | MDT |
|---|---|---|
| Price | $169.58 | $81.22 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 21 |
| Target Price | ★ $163.00 | $108.21 |
| AVG Volume (30 Days) | 571.1K | ★ 10.7M |
| Earning Date | 05-27-2026 | 06-03-2026 |
| Dividend Yield | 3.25% | ★ 3.58% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | N/A | ★ 2.76 |
| Revenue | N/A | ★ $33,537,000,000.00 |
| Revenue This Year | $19.43 | $8.91 |
| Revenue Next Year | $4.27 | $6.54 |
| P/E Ratio | ★ $17.46 | $29.12 |
| Revenue Growth | N/A | ★ 3.62 |
| 52 Week Low | $105.04 | $73.31 |
| 52 Week High | $170.49 | $106.33 |
Technical Indicators
Market Signals| Indicator | BMO | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 72.59 | 56.40 |
| Support Level | $122.60 | $73.85 |
| Resistance Level | N/A | $82.83 |
| Average True Range (ATR) | 3.01 | 1.52 |
| MACD | 0.15 | 0.57 |
| Stochastic Oscillator | 86.02 | 82.77 |
Price Performance
Historical ComparisonAbout BMO Bank Of Montreal
Bank of Montreal is a diversified financial services provider based in North America with over CAD 1.47 trillion in assets by the end of fiscal 2025. BMO operates four business segments: Canadian personal and commercial banking, US personal and commercial banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the US.
About MDT Medtronic plc.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.